Comprehensive study of a thyroxin-analog-based assay for free thyroxin ("Amerlex FT4")

Area of Science:

• Endocrinology
• Clinical Chemistry
• Biochemistry

Background:

• Radioimmunoassays for free thyroxin (FT4) are crucial diagnostic tools.
• Residual binding of tracer analogs to serum proteins can affect assay accuracy.
• Previous models did not fully account for these protein-binding effects.

Purpose of the Study:

• To extend the theory of thyroxin-analog-based radioimmunoassays for FT4.
• To definitively evaluate the effects of tracer analog binding to serum proteins.
• To assess the impact of these effects on the Amerlex FT4 radioimmunoassay results.

Main Methods:

• Utilized experimentally determined binding constants.
• Employed computer simulation techniques with an improved mathematical model.
• Compared simulation results with in vitro experimental and clinical data.

Main Results:

• The improved mathematical model accurately predicted FT4 assay results.
• Weak binding of the analog to thyroxin-binding globulin and prealbumin had negligible effects.
• Albumin binding introduced a small, quantifiable bias (0.08 pmol/L/g/L) in euthyroid samples.

Conclusions:

• The study provides a more accurate mathematical model for FT4 radioimmunoassays.
• The identified bias due to albumin binding is clinically insignificant for most samples.
• Assay results may be significantly affected in patients with genetic albumin abnormalities or high non-esterified fatty acids.